Earlybird's view
Thoughts and news from the Earlybird team
Latest
Earlybird’s Year in Review 2022
Earlybird’s Year in Review 2022
2022 was a rollercoaster of a year but one with resilience despite turbulence: Portfolio company wins accompanied team and regional growth…
Value Accrual in the Modern AI Stack
Value Accrual in the Modern AI Stack
“There are decades where nothing happens; and there are weeks where decades happen” — Lenin
From Hyper-scale to Hyper-downsize: How to Navigate Turbulent Times
From Hyper-scale to Hyper-downsize: How to Navigate Turbulent Times
5 Lessons from Simone Rüschenberg
Earlybird’s Engineering Team Welcomes 3 New Joiners
Earlybird’s Engineering Team Welcomes 3 New Joiners
As Venture Capital becomes more data-driven, automating processes and parsing a high volume of information — sorting signal vs. noise — and…
Trends and Pricing Models for Cell and Gene Therapy
Trends and Pricing Models for Cell and Gene Therapy
A Fierce Pharma article explored the treatment paradigm in the raising of cancer and rare disease, sharing the views of panellists at the…
Embedded Insurance — Why Will it Matter More in 2023?
Embedded Insurance — Why Will it Matter More in 2023?
A new wave of InsurTech companies democratizes access to embedded insurance for retailers of all sizes, providing higher flexibility and…